Hohl Benjamin bought ELVN
July 10, 2025 · Form 4 insider transaction
Hohl Benjamin bought 1,000 shares of Enliven Therapeutics, Inc. at $2.48 per share, a transaction worth $2.5K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,000
Price
$2.48
Total value
$2.5K
InsiderHohl Benjamin
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJuly 10, 2025
Filing dateJuly 14, 2025
Shares owned after24,000
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.